Innovating to beat cancer
Imagen was founded by two ex-AstraZeneca cell-biologists, leaders in the field of high content screening who pioneered research in systems biology and applications in personalised medicine.
Imagen’s vision of developing an accurate method of modelling cancer tumours in the lab culminated with the development of the predictRx platform. To date we’ve modelled over 150,000 patient treatments.
Together with experienced industry entrepreneurs, Imagen has grown to become a global provider of services to the pharmaceutical drug development industry through the launch of the predictTx platform.
Everything we do is informed by our unending drive to transform patient outcomes.
We are passionate about improving outcomes for cancer patients
We are driven by science, belief and ethics and seek to innovate
We are supportive and consultative, and work as a community
We continuously strive to learn, develop, and grow
Company registered in England and Wales with Company Registration No: 06373341
Full legal name: IMAGEN THERAPEUTICS LIMITED
Registered office address: The Innovation Centre | Vanguard House, Sci-Tech Daresbury Keckwick Lane, Daresbury WA4 4FS, UK
VAT number: GB 921 606 446
